GFP
ZBH icon

Gryphon Financial Partners’s Zimmer Biomet ZBH Stock Holding History

Gryphon Financial Partners’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-371
Closed -$40K – 850
2018
Q2 		$40K Sell
371
-12
-3% -$1.31K 0.02% 267
2018
Q1 		$40K Sell
383
-13
-3% -$1.51K 0.02% 260
2017
Q4 		$46K Buy
+396
New +$44.8K 0.03% 263

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Gryphon Financial Partners's ZBH Position: Q3 2018 in Review

Gryphon Financial Partners sold out of Zimmer Biomet (ZBH) in Q3 2018, closing a stake of 371 shares — an estimated $40K sold.

Gryphon Financial Partners first reported a position in ZBH in Q4 2017 and held it in 3 quarters. The position peaked at $46K in Q4 2017. 891 funds tracked by Wall St. Rank hold ZBH as of Q3 2018.

  • Gryphon Financial Partners reported no remaining Zimmer Biomet position as of Q3 2018 after selling out during the quarter.
  • Gryphon Financial Partners sold 371 Zimmer Biomet shares in Q3 2018, an estimated $40K.
  • Gryphon Financial Partners first reported a position in Zimmer Biomet in Q4 2017 and held it in 3 quarters.
  • Gryphon Financial Partners's Zimmer Biomet position peaked at $46K in Q4 2017.
  • 891 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2018.

Based on Gryphon Financial Partners's 13F filing for Q3 2018, filed 6 Nov 2018.